Foghorn Therapeutics Inc. Common Stock

FHTXNASDAQUSD
3.73 USD
0.01 (0.27%)AT CLOSE (11:59 AM EDT)
3.73
0.01 (0.13%)
POST MARKET (AS OF 04:16 PM EDT)
Post Market
AS OF 04:16 PM EDT
3.73
0.01 (0.13%)
🔴Market: CLOSED
Open?$3.73
High?$3.80
Low?$3.62
Prev. Close?$3.74
Volume?119.0K
Avg. Volume?151.7K
VWAP?$3.68
Rel. Volume?0.78x
Bid / Ask
Bid?$3.63 × 800
Ask?$3.93 × 200
Spread?$0.30
Midpoint?$3.78
Valuation & Ratios
Market Cap?219.0M
Shares Out?58.7M
Float?33.4M
Float %?56.9%
P/E Ratio?N/A
P/B Ratio?-2.87
EPS?-$1.28
Dividend?0.00%
Ex-Dividend?N/A

Foghorn Therapeutics Inc. Common Stock (FHTX) trades at $3.73 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (98.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Employees
106
Market Cap
219.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
83
Short Sent.?
42
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.15Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.01%Low
Short Interest?1.3M
Days to Cover?9.6
Free Float33.4M
Avg Daily Volume140.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.90Strong
Quick Ratio?2.90Strong
Cash Ratio?1.36Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
S&P
97
-2.87CHEAP
P/S?
Peers
100
S&P
14
7.76HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.7CHEAP
EV/Sales?
Peers
100
S&P
39
4.65FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
97
98.6%STRONG
ROA?
S&P
3
-33.9%WEAK
Cash Flow & Enterprise
FCF?$-87419000
Enterprise Value?$131.3M
Fundamentals ratios updated end of day